SS

Sanjeevarayappa Santhosh Kumar

Active Director Director DIN 11701647
DIN 11701647 First appointment May 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Sanjeevarayappa Santhosh Kumar

Data last updated:

Sanjeevarayappa Santhosh Kumar is a Director at Ackomed Pharma Private Limited (since 2026).

DIN 11701647
Primary Designation Director
First Appointment 09 May 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ackomed Pharma Private Limited U46497KA2026PTC220537
Director09 May 20262026Active

Board colleagues of Sanjeevarayappa Santhosh Kumar

NameDINCompanyDesignation
Channenahalli Shankarappa Kirankumar11701641Ackomed Pharma Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Ackomed Pharma Private Limited
Premium access

Shareholding and investment profile for Sanjeevarayappa Santhosh Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjeevarayappa Santhosh Kumar

Sanjeevarayappa Santhosh Kumar currently holds 1 directorship: Ackomed Pharma Private Limited (Director, since 09 May 2026).

Sanjeevarayappa Santhosh Kumar was first appointed on 09 May 2026 as Director at Ackomed Pharma Private Limited.

The current boards of Sanjeevarayappa Santhosh Kumar's companies include Channenahalli Shankarappa Kirankumar (Ackomed Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available